NCT05562323Recruiting
Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 27 Sept 2022
- Start date
- 14 Sept 2022
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- NCT number
- NCT05562323
What you commit to
- Study type: Observational
- Planned participants: 100
- From 14 Sept 2022 to the primary completion date, 1 Jul 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults at high risk of monkeypox who are getting the monkeypox vaccine, both with and without HIV. It studies their immune response.
- Age
- 18 years or older
- Sex
- All sexes can join
Main reasons for not taking part
- Any medical condition or finding that the investigator thinks could raise risks, interfere with the study or make the data hard to interpret
Read by machine on 9 Nov 2026.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participant has any medical condition and/or finding that in the investigator opinion might increase participant risks, interfere with the study or impair interpretation of study data.
Who the study is looking for
- Adult individuals of ≥18 years old.
- Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.
- Has understood the information provided and capable of giving informed consent.
Age in the registry: 18 years to - · Sex: All
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Germans Trias I Pujol Hospital | Badalona | Spain | Recruiting |
| VALLE HEBRÓN HOSPITAL/Centro Salud Internacional y Enfermedades Transmisibles Drassanes | Barcelona | Spain | Not yet recruiting |
| BCN Checkpoint | Barcelona | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.